Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cardiff Oncology (CRDF) Other Accumulated Expenses (2020 - 2025)

Historic Other Accumulated Expenses for Cardiff Oncology (CRDF) over the last 6 years, with Q3 2025 value amounting to $228000.0.

  • Cardiff Oncology's Other Accumulated Expenses fell 1678.83% to $228000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $228000.0, marking a year-over-year decrease of 1678.83%. This contributed to the annual value of $230000.0 for FY2024, which is 1111.11% up from last year.
  • Per Cardiff Oncology's latest filing, its Other Accumulated Expenses stood at $228000.0 for Q3 2025, which was down 1678.83% from $203000.0 recorded in Q2 2025.
  • Cardiff Oncology's 5-year Other Accumulated Expenses high stood at $419000.0 for Q1 2025, and its period low was $8000.0 during Q3 2022.
  • In the last 5 years, Cardiff Oncology's Other Accumulated Expenses had a median value of $122500.0 in 2021 and averaged $145583.3.
  • Per our database at Business Quant, Cardiff Oncology's Other Accumulated Expenses plummeted by 8095.24% in 2022 and then surged by 1111.11% in 2024.
  • Cardiff Oncology's Other Accumulated Expenses (Quarter) stood at $42000.0 in 2021, then plummeted by 80.95% to $8000.0 in 2022, then surged by 2487.5% to $207000.0 in 2023, then increased by 11.11% to $230000.0 in 2024, then fell by 0.87% to $228000.0 in 2025.
  • Its Other Accumulated Expenses stands at $228000.0 for Q3 2025, versus $203000.0 for Q2 2025 and $419000.0 for Q1 2025.